Fact-checked by Grok 2 weeks ago

Tonsil

The tonsils are bilateral masses of lymphoid tissue located in the pharynx, forming a ring of protective structures known as Waldeyer's ring that encircles the entrance to the respiratory and digestive tracts.^[1] They consist of four main types: the palatine tonsils, situated in the oropharynx between the palatoglossal and palatopharyngeal arches; the pharyngeal tonsil (adenoid), positioned on the roof of the nasopharynx; the lingual tonsil, embedded in the posterior third of the tongue; and the tubal tonsils, located near the openings of the Eustachian tubes.^[2] As components of the mucosa-associated lymphoid tissue (MALT), tonsils serve as a first line of immune defense by capturing antigens from inhaled or ingested pathogens via specialized M cells in their epithelium, initiating local immune responses through B-cell activation and production of immunoglobulins, particularly IgA.^[1] Tonsils develop embryologically from the second pharyngeal pouch during the fourth to fifth months of gestation, reaching peak size and activity between ages 4 and 12 before undergoing gradual atrophy after puberty.^[1] Their strategic positioning at the junction of the aerodigestive tracts enables them to sample and respond to environmental antigens, contributing to both humoral and cellular immunity without causing significant immunologic deficiency if surgically removed.^[2] Blood supply primarily arises from branches of the facial and ascending pharyngeal arteries, with lymphatic drainage directed to regional nodes such as the jugulodigastric group.^[1] Clinically, tonsils are notable for their involvement in conditions like tonsillitis, an inflammation often caused by viral or bacterial infections leading to symptoms such as sore throat and fever, and peritonsillar abscess, a potential complication requiring drainage.^[2] Tonsillectomy, the surgical removal of the palatine tonsils, is commonly performed for recurrent infections (e.g., seven episodes in one year) or obstructive sleep apnea, using techniques like electrocautery or cold dissection, with risks including postoperative hemorrhage.^[1] Despite their immune role, the presence of redundant lymphoid tissues elsewhere in the body ensures that tonsil removal does not broadly impair host defenses.^[1]

Anatomy and Structure

Gross Anatomy

The tonsils consist of aggregates of lymphoid tissue that form Waldeyer's tonsillar ring, a circular arrangement encircling the entrance to the oropharynx and comprising the palatine, pharyngeal, lingual, and tubal tonsils.^[1] This ring serves as a first line of defense in the upper aerodigestive tract.^[2] The palatine tonsils occupy the tonsillar fossae in the lateral walls of the oropharynx, situated between the anterior palatoglossal arch and the posterior palatopharyngeus arch.^[1] The pharyngeal tonsil, commonly referred to as the adenoid, is located on the posterior-superior wall of the nasopharynx.^[2] The lingual tonsil forms a nodular mass at the base of the tongue in the posterior third, while the tubal tonsils (also known as Gerlach's tonsils) are positioned laterally in the nasopharynx, surrounding the pharyngeal openings of the Eustachian tubes.^[3] The medial surface of the palatine tonsils is irregular, featuring 10-20 branched crypts that invaginate into the lymphoid tissue and facilitate antigen trapping by increasing surface area.^[4] These tonsils are bounded laterally by a fibrous capsule separating them from the superior constrictor muscle of the pharynx and are in proximity to major neurovascular structures, including the carotid sheath; the internal carotid artery lies approximately 2.5 cm posterolateral to the tonsillar fossa, and the internal jugular vein courses nearby within the sheath.^[1] Palatine tonsil size varies with age, typically larger in children—peaking between 7 and 10 years—before gradual involution in adults, where they measure approximately 2-3 cm in craniocaudal length.^[5] Clinically, palatine tonsil size is graded on a 0-4 scale (Brodsky scale), where grade 0 indicates tonsils confined within the fossa, grade 1 occupies ≤25% of the oropharyngeal airway, grade 2 occupies 26-50%, grade 3 occupies 51-75%, and grade 4 occupies >75%.^[6] The blood supply to the tonsils arises primarily from the tonsillar artery, a branch of the facial artery originating from the external carotid artery, with supplementary vessels including the ascending palatine, ascending pharyngeal, dorsal lingual, and lesser palatine arteries.^[1] Venous drainage occurs via the peritonsillar plexus into the pharyngeal venous plexus and ultimately the internal jugular vein.^[1] Sensory innervation is provided by the glossopharyngeal nerve (cranial nerve IX) via its tonsillar branches, while motor innervation to the surrounding pharyngeal muscles derives from the vagus nerve (cranial nerve X) through the pharyngeal plexus.^[1] Lymphatic drainage from the tonsils converges primarily to the jugulodigastric lymph nodes.^[2]

Microscopic Structure

The tonsillar tissue exhibits a layered organization consisting of a surface stratified squamous non-keratinizing epithelium that covers invaginated crypts, beneath which lies a dense lymphoid stroma featuring follicles with germinal centers primarily populated by B lymphocytes and parafollicular interfollicular regions enriched in T lymphocytes.^[7] The epithelium transitions to a reticular form within the crypts, where it intermingles with infiltrating lymphocytes, facilitating close interaction between epithelial and immune cells.^[8] Key cellular components include the stratified squamous epithelium on the surface, reticular epithelium lining the crypts, specialized microfold (M) cells overlying lymphoid aggregates for antigen sampling, and high endothelial venules that support lymphocyte trafficking into the tissue.^[7] Additionally, mucus-secreting goblet cells are absent in palatine tonsils but present in pharyngeal tonsils, while plasma cells derived from B lymphocytes and macrophages reside within the lymphoid compartments to contribute to local immune surveillance.^[8]^[7] Extracellular elements comprise a connective tissue stroma of type III collagen septa that encapsulates the lymphoid follicles, providing structural support without afferent lymphatic vessels—a distinctive feature of tonsillar tissue that relies on direct antigen exposure via the epithelium.^[7] Among tonsil types, palatine tonsils feature deeper, more numerous crypts (10–30 per tonsil) lined by reticular epithelium, contrasting with the pharyngeal tonsils' flatter pseudostratified ciliated columnar epithelium and fewer, shallower crypts integrated into mucosal folds.^[7]^[8] Quantitatively, tonsillar tissue harbors a high density of lymphocytes, with up to 10^9 lymphoid cells per palatine tonsil, predominantly B and T cells, alongside scattered plasma cells and macrophages.^[9]

Development and Histogenesis

Embryonic Development

The tonsillar ring originates from interactions between endodermal and mesodermal tissues during the early embryonic development of the pharyngeal apparatus. The palatine tonsils develop primarily from the endoderm of the second pharyngeal pouch, forming epithelial buds that invaginate into the surrounding mesenchyme. The pharyngeal tonsil (adenoid) arises from the endodermal epithelium lining the roof of the nasopharynx through the fusion of two lateral primordia.^[10] Other components of the ring, including the tubal and lingual tonsils, arise from endodermal epithelium associated with the second pouch, supplemented by mesodermal contributions that provide the supportive connective tissue framework; the third and fourth pouches contribute indirectly to adjacent structures influencing tonsillar differentiation.^[11]^[12]^[13] The timeline of tonsillar formation begins with the appearance of the palatine tonsil anlage around 8 weeks of gestation, marked by epithelial invaginations from the pharyngeal endoderm into the underlying mesenchyme. Initial lymphoid primordia emerge at 3-4 months of gestation (approximately 12-16 weeks), as mononuclear wandering cells begin to populate the developing tissues. By the 14th week, these processes accelerate, establishing the foundational architecture for lymphoid infiltration.^[14]^[4]^[15] Key developmental processes involve epithelial proliferation, which generates the characteristic crypts of the tonsils, and mesenchymal infiltration by lymphoid precursors migrating from the bone marrow. These precursors, including early T- and B-lymphocytes, integrate into the epithelial-mesenchymal interface around the 16th week, forming distinct T-cell and B-cell regions that support initial immunocompetent maturation. This infiltration differentiates the tonsils as secondary lymphoid organs, analogous to the thymus in their role in adaptive immunity development.^[15]^[16]^[17] Fetal milestones include the detection of organized lymphoid tissue in the tonsillar structures between 14 and 20 weeks of gestation, with both T- and B-lymphocyte classes present by mid-gestation. The complete tonsillar ring achieves its basic form by birth, providing a protective lymphoid barrier in the pharynx ready for postnatal expansion.^[17]^[4]

Postnatal Development

Following birth, the palatine tonsils undergo rapid hypertrophy driven by exposure to environmental antigens, leading to lymphoid proliferation and increased tissue volume. This growth phase is most pronounced in infancy and early childhood, with tonsil volume approximately doubling from birth to age 4 years as follicles and germinal centers develop.^[18] By ages 6-7 years, the tonsils reach a peak in size relative to the pharyngeal airway, reflecting maximal hyperplasia before the onset of relative decline.^[19] The adenoids, or pharyngeal tonsils, follow a similar trajectory but peak earlier, around age 6, and begin regressing by ages 8-10 in most cases, with significant size decrease observed by early adolescence.^[20]^[21] During puberty, the palatine tonsils achieve their absolute maximum size, often in early adolescence around ages 12-14, after which gradual atrophy commences. This involution is influenced by hormonal shifts, including rising androgen levels that promote lymphoid tissue regression and fibrous replacement.^[22] By late adolescence, tonsil size stabilizes or decreases, with cross-sectional studies showing an approximately 30% reduction in measured area from late childhood to young adulthood.^[19] Adenoid regression accelerates during this period, though complete involution varies individually.^[21] In adulthood, the involution process continues, with lymphoid elements progressively replaced by fibrous and fatty tissue, leading to substantial overall volume reduction.^[13] This structural decline correlates with diminished immune surveillance capacity, though residual tonsillar function persists into senescence.^[23] Several factors modulate tonsillar development, including recurrent infections that accelerate early hypertrophy through chronic antigenic stimulation, nutritional deficiencies that may impair lymphoid maturation, and genetic predispositions linked to familial patterns of hyperplasia or recurrent inflammation.^[24] For instance, inherited immune response variations can predispose children to exaggerated tonsillar growth, independent of environmental exposures.^[25]

Physiological Function

Immunological Role

The tonsils function as a critical component of nasopharyngeal-associated lymphoid tissue (NALT), serving as the primary inductive site for mucosal immune responses in the upper respiratory and oral tracts. Positioned at the gateway to both the respiratory and digestive systems, they act as sentinels that continuously monitor and respond to airborne and ingested antigens, initiating localized adaptive immunity to prevent pathogen invasion. This role is evolutionarily conserved across mammals, where tonsillar structures have developed as entry-point defenses, with increasing crypt formation and lymphoid proliferation in response to antigenic challenges over phylogenetic lines.^[26] Antigen sampling in the tonsils occurs primarily through specialized microfold (M) cells located in the follicle-associated epithelium overlying the crypts, which endocytose particulates and pathogens from the luminal surface. These M cells transport antigens to underlying antigen-presenting cells (APCs) in the subepithelial regions, facilitating efficient uptake without the need for systemic dissemination. The extensive crypt architecture further enhances this process by trapping microbial debris and soluble antigens, allowing prolonged exposure to immune effectors and promoting a robust local response.^[27]^[28] Once sampled, antigens are processed by dendritic cells (DCs) and macrophages within the tonsillar interfollicular and extrafollicular areas, where they are internalized, degraded, and presented via major histocompatibility complex (MHC) class II molecules to naive CD4+ T cells. This presentation activates T helper cells, which differentiate into follicular helper T (Tfh) cells that migrate to germinal centers (GCs), providing essential costimulatory signals (e.g., CD40L and IL-21) to support B-cell proliferation and differentiation. The balance between tolerance and response is maintained by regulatory mechanisms involving DCs, preventing excessive inflammation while priming effective defenses against commensals and pathogens.^[27]^[29]^[28] In the GCs, activated B cells undergo class-switch recombination, predominantly to IgA isotypes, with Tfh-derived cytokines driving the production of dimeric secretory IgA (sIgA) that coats mucosal surfaces to neutralize toxins and inhibit microbial adhesion. Approximately 25% of tonsillar plasma cells express IgA, contributing significantly to the mucosal barrier and disseminating IgA-secreting cells to distant sites via the bloodstream.^[30] This process also generates long-lived memory B cells, enhancing secondary responses and linking tonsillar immunity to broader protection.^[27]^[29]^[28] A distinctive feature of tonsillar immunity is the absence of afferent lymphatics, which precludes drainage from peripheral tissues and instead relies on direct recruitment of circulating naive lymphocytes through high endothelial venules (HEVs). These HEVs express adhesion molecules (e.g., PNAd) and chemokines (e.g., CCL19, CCL21, CXCL13) that facilitate the selective entry of B and T cells, ensuring rapid population of inductive sites with antigen-naive effectors. This vascular-dependent trafficking underscores the tonsils' role as an autonomous, blood-borne immune outpost.^[31]^[29] The tonsils exhibit peak immunological activity during childhood, particularly between ages 5 and 7, when the number of IgA-producing immunocytes reaches its maximum, contributing significantly to mucosal immunity in the upper respiratory tract.^[32] This period coincides with robust lymphocyte proliferation, including higher proportions of B cells (CD19+) and activated B cells (CD38+), which support enhanced antibody secretion and germinal center formation essential for adaptive responses to pathogens.^[33] By this age, tonsillar tissues play a dominant role in local IgA production, facilitating mucosal immune defense against inhaled antigens.^[32] During adolescence, tonsillar function transitions from a primarily inductive site—where naive lymphocytes are activated—to a more effector-oriented role, marked by reduced hyperplasia following repeated antigen exposures.^[34] Proportions of germinal center B cells and T follicular helper cells begin to decline steadily after puberty, reflecting an adaptation to cumulative immune challenges and a shift toward memory responses rather than primary expansion.^[35] This involution is accompanied by increasing CD4+ T cells and memory T cells (CD45RO+), maintaining some responsiveness but with diminished proliferative capacity compared to childhood.^[33] In adulthood, tonsillar immune activity sustains at a lower level due to stabilized but reduced B cell populations and emerging fibrosis from stromal cells like PI16+ reticular cells, which limit antigen sampling and germinal center dynamics.^[33]^[36] Metabolomic profiles shift, showing elevated glucose but decreased levels of glycine and phosphocholine, indicative of waning immunometabolic support for lymphocyte function.^[37] Senescence after age 50 involves pronounced decline, including significant reductions in germinal centers and impaired T-cell homing, driven by age-related decreases in GC-specific T follicular helper cells and overall lymphoid follicle size.^[38]^[39] This leads to heightened susceptibility to respiratory infections, as innate immune cells like granulocytes accumulate without fully restoring adaptive efficacy.^[40] Influencing factors include cumulative antigen load from lifelong exposures, which accelerates B cell subset shifts; hormonal variations, such as estrogen in females potentially delaying functional decline; and microbiome alterations that modulate local inflammation and stromal remodeling.^[33]^[36] Clinically, childhood tonsillar hypertrophy bolsters immunity but predisposes to airway obstruction, while age-related atrophy correlates with increased recurrent infections.^[23]

Clinical Significance

Infections and Inflammatory Conditions

Infections and inflammatory conditions of the tonsils primarily involve acute or chronic responses to microbial pathogens or, less commonly, non-infectious triggers, leading to inflammation of the palatine tonsils and surrounding tissues. These disorders are among the most frequent reasons for seeking medical care in pediatric and adolescent populations, often presenting with pharyngeal pain and systemic symptoms. Bacterial etiologies, particularly group A beta-hemolytic Streptococcus (GABHS, Streptococcus pyogenes), account for 15% to 30% of cases in children, while viral infections predominate in 70% to 95% of instances overall.^[41]^[42] Acute tonsillitis manifests as sudden-onset sore throat, fever, odynophagia (painful swallowing), and dysphagia, often accompanied by tonsillar erythema, edema, and exudate. Viral causes include common pathogens such as Epstein-Barr virus (EBV), adenovirus, and influenza, which typically resolve without antibiotics and may involve additional symptoms like rhinorrhea or cough. Bacterial tonsillitis, most often due to S. pyogenes, lacks prominent viral features and carries risks of suppurative complications or postinfectious sequelae like rheumatic fever. Clinical assessment often employs the Centor criteria—fever, tonsillar exudate, tender anterior cervical lymphadenopathy, and absence of cough—to stratify the likelihood of GABHS infection, guiding decisions for testing in patients aged 3 to 14 years.^[43]^[44]^[41] Epidemiologically, tonsillitis peaks in children aged 5 to 15 years, with bacterial etiologies accounting for 15% to 30% of cases in this age group due to close-contact transmission in settings like classrooms. Risk factors include exposure to infected individuals in crowded environments, immunosuppression, and environmental irritants such as tobacco smoke, which impairs mucosal defenses and increases susceptibility. Incidence is lower in adults, where viral etiologies predominate, though recurrent cases can occur across ages.^[45]^[46]^[47] A serious complication of acute tonsillitis is peritonsillar abscess (quinsy), occurring rarely in untreated or inadequately managed cases, characterized by pus accumulation in the peritonsillar space between the tonsillar capsule and pharyngeal musculature. This leads to unilateral tonsillar displacement, trismus (difficulty opening the mouth), and severe odynophagia, often requiring urgent intervention to prevent airway compromise or spread to deeper spaces. Predominantly caused by polymicrobial infections including S. pyogenes and anaerobes, it arises from progression of tonsillar infection through the capsule.^[48]^[49] Chronic tonsillitis involves persistent or recurrent inflammation, defined clinically by multiple episodes (e.g., seven or more in one year, five per year for two years, or three per year for three years) of acute symptoms, often with cryptic tonsils harboring debris. Pathogenesis frequently implicates bacterial biofilms—structured communities of pathogens like S. pyogenes and Haemophilus influenzae adherent to tonsillar crypts—that confer antibiotic resistance and perpetuate reinfection. These biofilms contribute to treatment failure and the cycle of recurrence, distinguishing chronic from isolated acute events.^[50]^[51]^[52] Non-infectious inflammatory conditions affecting the tonsils include allergic hypertrophy, where chronic exposure to allergens causes tonsillar enlargement and lymphoid hyperplasia without microbial invasion, mimicking infectious edema. Additionally, systemic disorders like Kawasaki disease may involve tonsillar inflammation as part of mucocutaneous manifestations, presenting with persistent fever, strawberry tongue, and pharyngeal erythema in young children, though the tonsils are not the primary site. These cases highlight the need to differentiate from infectious etiologies through history and ancillary testing.^[53]^[54] Diagnosis of tonsillar infections relies on clinical evaluation supplemented by targeted testing to distinguish bacterial from viral causes and identify complications. Rapid antigen detection tests (RADT) for GABHS, performed via throat swab, offer quick results with high specificity (95%) but moderate sensitivity (70% to 90%), prompting confirmatory throat culture in negative pediatric cases to avoid missing infections. For suspected peritonsillar abscess, imaging such as contrast-enhanced computed tomography (CT) or ultrasound confirms fluid collections and guides management, while viral serologies or monospot tests aid in EBV confirmation when indicated.^[42]^[55]^[56]

Surgical and Therapeutic Interventions

Tonsillectomy, the surgical removal of the palatine tonsils, is primarily indicated for recurrent tonsillitis meeting the Paradise criteria, which include at least seven documented episodes of sore throat in the preceding year, five or more episodes per year for two years, or three or more episodes per year for three years, accompanied by specific clinical features such as fever, cervical adenopathy, tonsillar exudate, or positive streptococcal testing.^[57] Other indications encompass tonsillar hypertrophy causing obstructive sleep apnea or suspected tonsillar malignancy, though recurrent infection remains the most common rationale.^[57] Surgical techniques vary, with traditional cold steel dissection involving scalpel incision and ties or ligatures for hemostasis, offering precise tissue removal but potentially longer operative times.^[58] Electrocautery uses electrical current for cutting and coagulation, reducing intraoperative blood loss compared to cold steel, while coblation employs radiofrequency energy in a saline medium to ablate tissue at lower temperatures, resulting in less postoperative pain and faster healing.^[59]^[60] Adenoidectomy, the excision of nasopharyngeal lymphoid tissue, is frequently performed concurrently with tonsillectomy to address nasal obstruction, chronic rhinosinusitis, or otitis media with effusion, particularly in pediatric patients.^[61] Historically, the procedure evolved from guillotine methods in the late 19th century, which used a sliding blade for rapid tissue severance but risked incomplete removal, to curettage techniques introduced in the 1880s involving a curette scraped across the adenoid bed under direct visualization.^[61] Modern approaches favor powered microdebrider-assisted adenoidectomy, which employs a rotating blade and suction for precise, endoscopic-guided resection, minimizing trauma to surrounding structures like the Eustachian tube orifice.^[62] Common complications of tonsillectomy and adenoidectomy include postoperative hemorrhage, occurring in approximately 2-5% of cases overall, with primary hemorrhage (within 24 hours) at rates below 1% and secondary hemorrhage (after 24 hours) ranging from 1-3%, often necessitating return to the operating room in severe instances.^[63] Infections may arise postoperatively, typically managed with antibiotics, while velopharyngeal insufficiency, leading to hypernasal speech or regurgitation, is a rarer sequela, particularly after adenoidectomy in younger children with submucous cleft palate.^[57] Therapeutic alternatives to surgery for recurrent tonsillitis include watchful waiting for patients not meeting Paradise criteria, which avoids operative risks while monitoring episode frequency.^[64] Antibiotic therapy, such as penicillin V for confirmed group A beta-hemolytic streptococcal infections, serves as first-line treatment to eradicate bacterial pathogens and prevent rheumatic fever.^[64] Corticosteroids may be administered intraoperatively to reduce edema and pain, though routine use for ongoing inflammation is not recommended without specific indications.^[65] Postoperative outcomes demonstrate significant efficacy, with tonsillectomy significantly reducing the frequency of throat infections in the first two years following surgery, alongside improvements in quality of life.^[66] In adults, the procedure has minimal long-term immune impact due to compensatory mechanisms in the mucosal immune system, though it may slightly elevate risks for certain respiratory conditions.^[67] Recent advances include laser-assisted tonsillectomy, such as CO2 laser techniques, which provide superior hemostasis and shorter operative times compared to conventional methods, with reduced blood loss.^[68] Radiofrequency ablation, including coblation variants, offers targeted tissue reduction with lower thermal injury, leading to decreased postoperative morbidity and faster return to normal diet in studies from the 2010s onward.^[69] More recent advancements as of 2025 include powered intracapsular tonsillectomy and low-temperature plasma techniques, which offer reduced postoperative pain and hemorrhage risks.^[70]^[71]

References

[1]
Anatomy, Head and Neck: Tonsils - StatPearls - NCBI Bookshelf
Jul 26, 2025 · Structure and Function ... Like other lymphoid tissues, the tonsils contribute to immune defense by responding to infections and foreign antigens.Introduction · Structure and Function · Surgical Considerations
[2]
The Tonsils (Waldeyer's Ring) - Lingual - Pharyngeal - Palatine - Tubal
They have an important role in fighting infection – the first line of defence against pathogens entering through the nasopharynx or oropharynx. In this article ...
[3]
Waldeyer's ring: Definition, anatomy and pathology - Kenhub
Waldeyer's ring consists of four tonsillar structures (namely, the pharyngeal, tubal, palatine and lingual tonsils) as well as small collections of lymphatic ...
[4]
Anatomy, Head and Neck, Palatine Tonsil (Faucial Tonsils) - NCBI
Jun 5, 2023 · The palatine tonsils drain to the jugulodigastric node, a node of the deep cervical lymph nodes, located inferior to the angle of the mandible.
[5]
Palatine Tonsil Measurements and Echogenicity during Tonsillitis ...
Feb 15, 2023 · The MRI studies performed by Aren [43] found that the palatine tonsil reaches a maximum size between seven and ten years and then gradually ...
[6]
Reproducibility of Clinical Grading of Tonsillar Size - JAMA Network
Feb 15, 2010 · The Brodsky grading scale comprised the following 5 grades: grade 0 (tonsils within the tonsillar fossa), grade 1 (tonsils just outside of the ...
[7]
https://doi.org/10.1016/j.wjorl.2021.04.003
[8]
Biological significance of palatine tonsillar epithelium
The palatine tonsil is covered by 15-20 layers of either flattened non-keratinised- or parakeratinised squamous epithelium resting on a basement membrane. A ...
[9]
Isolation of Mononuclear Cells From Tonsillar Tissue - Ryon - 1991
Total mononuclear cell yields will range from 5 × 108 to 5 × 109 cells per pair of tonsils. B cells comprise 60% to 70% of the cell population after Ficoll ...
[10]
Embryology, Pharyngeal Pouch - StatPearls - NCBI Bookshelf - NIH
Apr 3, 2023 · Pharyngeal pouches are endodermal out-pockets occurring between the pharyngeal arches in embryological development.
[11]
[PDF] Head and Neck Embryology: An Overview of Development, Growth ...
May 10, 2009 · The second pouch becomes segmented and one of the segments forms the tonsils and lymphatic nodules. The third pouch forms bulbous portions ...
[12]
Tonsil and Adenoid Anatomy - Medscape Reference
Apr 4, 2025 · The histological organization of the tonsils allows them to function as a first line of defense against pathogens entering through the oral or ...
[13]
[Differentiation of the palatine tonsillar tissues of the human fetus]
The anlage of the palatine tonsils appears at the age of 9 weeks of fetal development. At the age of 13-14 weeks of fetal development the tonsil suspension ...
[14]
The development of the human tonsilla palatina - PubMed
The development of the tonsilla palatina starts during the 14th gw when the mesenchyme underlying the mucous membrane of the tonsillar cavity becomes invaded ...Missing: embryonic | Show results with:embryonic
[15]
Craniofacial Development - Duke Embryology
Pharyngeal Pouch 2 –forms numerous infoldings that become the crypts of the palatine tonsil; later, lymphocytes (from the thymus and bone marrow) infiltrate the ...Missing: timeline | Show results with:timeline
[16]
[Embryogenesis of the human pharyngeal tonsil] - PubMed
Occupation of the organ with lymphocytes takes place on the 16th week of development. The embryos possess already two classes of T- and B-lymphocytes and their ...
[17]
Age-dependent changes in the adenoids (Ad) and tonsils (Tn). Error ...
The tissues begin to develop from birth, growing approximately 200 % in size by the age of 4-7 years, at which point the adenoids involute; however, the tonsils ...
[18]
Patterns of adenoid and tonsil growth in Japanese children ... - Nature
Nov 20, 2018 · Lymphoid tissues, such as adenoids (Ad) and tonsils (Tn), are suggested to undergo hypertrophy during childhood and involution in adulthood.Missing: postnatal | Show results with:postnatal
[19]
Anatomy and physiology of the palatine tonsils, adenoids, and ... - NIH
The medial epithelial surface of the tonsil forms from the second branchial pouch, as solid epithelial cores invaginate into the surrounding mesenchyme.Missing: embryonic origin
[20]
Developmental anatomy of the tonsil and its implications for ...
In senescence, there is involution of the lymphoid elements and proliferation of fibrous tissue in the capsule and trabeculae. The overall bulk of the tonsil is ...
[21]
Differential changes in the adenoids and tonsils in Japanese ...
Aug 29, 2017 · In the present study, there was a significant decrease in the size of the Ad and Tn relative to the upper airway, from the ages of 6 to 20 years ...Missing: birth | Show results with:birth
[22]
Age-related changes of the innate immune system of the palatine ...
Jun 28, 2023 · We could observe a strong accumulation of all granulocyte subsets in the aging tonsil, which was most pronounced for basophils and mast cells.<|separator|>
[23]
Unveiling the Enigmatic Adenoids and Tonsils: Exploring ... - MDPI
After birth, the tonsils develop multiple branching crypts, with approximately 10–30 per tonsil. These crypts have a fibrovascular core surrounded by lymphoid ...Missing: involution | Show results with:involution
[24]
Familial and Environmental Risk Predisposition in Tonsillectomy
Jul 21, 2020 · This study reveals that genetic predisposition factors may have a role for tonsillectomy and its underlying causative indications. Also, it ...Missing: nutrition | Show results with:nutrition
[25]
Palatine tonsils--their evolution and ontogeny - PubMed
The tonsil develops from a doubled primordium and consists of two lobes. Attention is drawn to the close relation between tonsils and glands.Missing: conservation sentinel
[26]
The Immune Response in Adenoids and Tonsils - Karger Publishers
May 19, 2000 · The main function of these structures is to sample antigens, have them surveyed locally by immune cells in order to destroy them and generate ...
[27]
Mucosal immune response in biology, disease prevention ... - Nature
Jan 8, 2025 · The activation of T cells further promotes the formation of GC in the NALT, where B cells undergo IgA class switching and affinity maturation, ...
[28]
Potential of Nasopharynx-associated Lymphoid Tissue for Vaccine ...
Nov 4, 2010 · Nasopharynx-associated lymphoid tissue (NALT), constituting Wal- deyer's ring in humans, is a unique inductive site for B-cell responses.
[29]
Differences in Lymphocyte Subsets in the Wall of High Endothelial ...
Dec 25, 2001 · As tonsils have no afferent lymphatics the blood vessels are the only entry site. The second aim was to characterize lymphocytes in the lumen of ...
[30]
Age-related Changes of IgA Immunocytes and Serum and Salivary ...
Total number of IgA immunocytes was the highest at the age of 5 to 7 with a decline by age, especially at the age of 19 in the controls. In the tonsillectomy ...
[31]
Age-dependent altered proportions in subpopulations of tonsillar ...
Substantial changes in major tonsillar T and B cell populations as shown in this study may have an impact on the ageing process of the immune system.
[32]
Role of germinal center and CD39highCD73+ B cells in the age ...
Apr 12, 2024 · Germinal center population steadily decreases with increasing age. Human tonsils were procured from patients aged between 2 and 39 years old (N ...
[33]
Role of germinal center and CD39highCD73+ B cells in the age ...
Apr 12, 2024 · Based on the reduction of their size since puberty, they are thought to experience involution in adulthood. In this context, we have used ...
[34]
PI16+ reticular cells in human palatine tonsils govern T ... - PubMed
Here, we show that human tonsillar FRCs undergo dynamic reprogramming during life and respond vigorously to inflammatory perturbation in comparison to other ...Missing: related | Show results with:related
[35]
Differences in the metabolomic profile of the human palatine tonsil ...
Jul 31, 2023 · These results improve our understanding of metabolic changes in the PT with aging and serve as a basis for future tonsil-related metabolomic ...
[36]
https://pubmed.ncbi.nlm.nih.gov/37202490/
[37]
Parallel comparison of T cell and B cell subpopulations of adenoid ...
Apr 14, 2025 · The adenoids and tonsils are important immune organs of the nasopharynx that often become hypertrophic in childhood because of recurrent ...<|separator|>
[38]
Age-related changes of the innate immune system of the palatine ...
Jun 29, 2023 · We could observe a strong accumulation of all granulocyte subsets in the aging tonsil, which was most pronounced for basophils and mast cells.
[39]
Tonsillitis and Tonsilloliths: Diagnosis and Management - AAFP
Tonsillitis is caused by a viral infection in 70% to 95% of cases. However, bacterial infections caused by group A beta-hemolytic streptococcus (Streptococcus ...Sort: Key Recommendations... · Tonsillitis · Centor Score To Guide...Missing: epidemiology | Show results with:epidemiology
[40]
Tonsillitis - StatPearls - NCBI Bookshelf - NIH
Jul 7, 2025 · The condition is typically caused by viral or bacterial infections and manifests with symptoms such as sore throat, fever, odynophagia, and ...Tonsillitis · Evaluation · Treatment / Management
[41]
Tonsillitis - Symptoms & causes - Mayo Clinic
Aug 12, 2025 · Common viruses most often cause tonsillitis. But bacterial infections also can be the cause. The most common bacterium causing tonsillitis is ...Overview · Symptoms · ComplicationsMissing: epidemiology | Show results with:epidemiology
[42]
Acute tonsillitis and pharyngitis - Knowledge @ AMBOSS
Aug 21, 2025 · Acute tonsillitis and pharyngitis are particularly common in children and young adults and are primarily caused by viruses or group A streptococci ( GAS ).
[43]
Tonsillitis and Peritonsillar Abscess - Medscape Reference
Aug 2, 2024 · Viral or bacterial infections and immunologic factors lead to tonsillitis and its complications. Overcrowded conditions and malnourishment ...
[44]
Tonsillitis - Symptoms, Causes, Images, and Treatment Options
Patients with acute streptococcal tonsillitis will often report a sudden onset of sore throat and have pain on swallowing. The sore throat is typically ...
[45]
Tonsillitis - Clinical Features - Management - TeachMePaediatrics
Jul 28, 2023 · It is worth noting that grade II and III tonsils are at peak incidence at 4-5 years old. Until the age of 6, grade II tonsils predominate ...
[46]
Peritonsillar Abscess - StatPearls - NCBI Bookshelf - NIH
Peritonsillar abscess, also known as quinsy, is the localized collection of pus in peritonsillar space between the tonsillar capsule and superior constrictor ...
[47]
Peritonsillar Abscess: Practice Essentials, Anatomy, Pathophysiology
Sep 3, 2024 · PTA is usually a complication of an acute tonsillitis. Inflammatory edema may lead to significant difficulty in swallowing. Dehydration ...
[48]
Chronic tonsillitis and biofilms: a brief overview of treatment modalities
Sep 5, 2018 · The cause of such recurrent infections have been identified as microorganisms which often create biofilms and a repository of infection in the ...
[49]
Understanding the Role of Biofilms in Acute Recurrent Tonsillitis ...
Feb 21, 2024 · Acute recurrent tonsillitis is a chronic, biofilm-related infection that is a significant burden to patients and healthcare systems.
[50]
Evidence of Bacterial Biofilms among Infected and Hypertrophied ...
This was similar to previous investigators where they have confirmed the hypothesis that chronic and recurrent tonsillitis are biofilm-related [56, 57].<|separator|>
[51]
Environmental and non-infectious factors in the aetiology of ... - NIH
Non-infectious causes of sore throat include: physico-chemical factors, such as smoking, snoring, shouting, tracheal intubation, medications, or concomitant ...
[52]
Incomplete Kawasaki disease presenting as complicated acute ...
Jun 12, 2025 · Discussion: Suspected complicated tonsillitis failing to respond to adequate treatment should raise suspicion of KD. Prompt treatment is ...
[53]
Testing for Strep Throat or Scarlet Fever | Group A Strep - CDC
Aug 7, 2025 · A rapid strep test involves swabbing the throat and running a test on the swab. The test quickly shows if group A strep bacteria are likely causing the illness.
[54]
Tonsillitis and Peritonsillar Abscess Workup - Medscape Reference
Aug 2, 2024 · A rapid antigen detection test (RADT), also known as the rapid streptococcal test, detects the presence of GABHS cell wall carbohydrate from ...
[55]
Clinical Practice Guideline: Tonsillectomy in Children (Update)
Specifically, the goals are to educate clinicians, patients, and/or caregivers regarding the indications for tonsillectomy and the natural history of recurrent ...
[56]
Coblation Versus Conventional Methods for Tonsillectomy - Lippincott
Conclusion: Coblation is a safe technique that appears to offer reduced levels of postoperative pain, shorter operative time and less blood loss in comparison ...
[57]
Outcomes of coblation tonsillectomy versus bipolar electrocautery ...
Nov 26, 2022 · Coblation tonsillectomy is associated with less pain severity and shorter pain duration, fewer bleeding incidents, and more prompt healing.
[58]
Coblation versus traditional tonsillectomy: A double blind ... - NIH
This study revealed a significantly less intraoperative or postoperative complications and morbidity in coblation tonsillectomy in comparison with traditional ...
[59]
Evolution of Adenoid Surgery | IntechOpen
Adenoid mass increases in size rapidly after birth. It reaches its maximum size by 7–10 years of age. After that, it begins to regress and gradually diminishes ...
[60]
Comparison between curettage adenoidectomy and endoscopic ...
Adenoidectomy, a technique in which nasopharyngeal lymphoid tissue is removed, was first described as curettage (conventional) adenoidectomy in 1885. Standard ...Missing: guillotine | Show results with:guillotine
[61]
Primary and secondary postoperative hemorrhage in pediatric ... - NIH
Mar 6, 2021 · The incidence rate of post-tonsillectomy hemorrhage was 1.83%, and secondary hemorrhage was a major component.
[62]
Tonsillitis and Tonsilloliths: Diagnosis and Management - AAFP
Jan 1, 2023 · Watchful waiting is typically preferred over tonsillectomy for recurrent ton- sillitis if there have been less than seven episodes in the ...
[63]
Tonsillectomy in Children: Update to Guidelines for Treating and ...
Feb 5, 2019 · Clinicians should notadminister or prescribe perioperative antibiotics to children undergoing tonsillectomy. KAS11: Intraoperative SteroidsMissing: alternatives | Show results with:alternatives
[64]
Association of Long-Term Risk of Respiratory, Allergic, and ... - NIH
Jun 7, 2018 · Tonsillectomy did not reduce the risk of respiratory diseases in adults, but it may increase inflammatory bowel disease risk, and ...
[65]
The efficacy of carbon dioxide laser applications in tonsillectomy - NIH
Oct 30, 2025 · Some studies suggest that CO₂ laser-assisted tonsillectomy offers superior haemostasis and reduced postoperative discomfort, while others report ...
[66]
Review of Radiofrequency Ablation in Tonsillectomy - PMC - NIH
May 17, 2021 · Studies in Favour of Radiofrequency Ablation ... A retrospective study was done by Verma et al. comparing the various techniques of tonsillectomy.